An AI tool built to find faint cancer markers in routine tissue slides is headed for lab trials, as QIMR Berghofer tests a ...
A multimodal AI model improved neuroblastoma diagnosis, molecular prediction, and risk stratification using routine pathology ...
Revna Biosciences, Ghana's first precision medicine company, is contributing to transforming the landscape of healthcare in Ghana by offering advanced molecular tests for oncology, infectious diseases ...
IMS and SUM Hospital becomes first in Odisha to set up a comprehensive in-house genomics laboratory, enabling advanced cancer ...
Researchers identified a six-gene signature in microscopic colorectal cancer (CRC) liver metastases that may help predict ...
Alzheimer's blood test p-tau217 predicts 78% cognitive decline risk within ten years in symptom-free older adults, a JAMA ...
The WHO predicts cancer cases could nearly double by 2050. Experts explain how science is fighting back with faster diagnosis ...
Sarcoma is a rare cancer that often begins as a painless lump. Experts stress that early diagnosis improves treatment and ...
Obstacles to free, essential biomarker testing remain as reimbursement negotiations begin, and eligibility criteria require ...
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial ...
Obicetrapib, a cholesterol-lowering drug already in Phase 3 cardiovascular trials, significantly reduced a validated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results